- Home
- RR vs GALT Comparison
RR vs GALT Comparison
Compare RR & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RR
- GALT
- Stock Information
- Founded
- RR 2016
- GALT 2000
- Country
- RR United States
- GALT United States
- Employees
- RR N/A
- GALT N/A
- Industry
- RR
- GALT Biotechnology: Pharmaceutical Preparations
- Sector
- RR
- GALT Health Care
- Exchange
- RR Nasdaq
- GALT Nasdaq
- Market Cap
- RR 273.2M
- GALT 232.3M
- IPO Year
- RR 2023
- GALT N/A
- Fundamental
- Price
- RR $2.53
- GALT $4.60
- Analyst Decision
- RR Strong Buy
- GALT Strong Buy
- Analyst Count
- RR 1
- GALT 3
- Target Price
- RR $3.50
- GALT $6.00
- AVG Volume (30 Days)
- RR 30.0M
- GALT 241.8K
- Earning Date
- RR 08-11-2025
- GALT 08-14-2025
- Dividend Yield
- RR N/A
- GALT N/A
- EPS Growth
- RR N/A
- GALT N/A
- EPS
- RR N/A
- GALT N/A
- Revenue
- RR $4,126,000.00
- GALT N/A
- Revenue This Year
- RR $20.24
- GALT N/A
- Revenue Next Year
- RR $130.19
- GALT N/A
- P/E Ratio
- RR N/A
- GALT N/A
- Revenue Growth
- RR N/A
- GALT N/A
- 52 Week Low
- RR $0.52
- GALT $0.73
- 52 Week High
- RR $5.20
- GALT $4.71
- Technical
- Relative Strength Index (RSI)
- RR 53.43
- GALT 69.41
- Support Level
- RR $2.97
- GALT $3.93
- Resistance Level
- RR $3.59
- GALT $4.35
- Average True Range (ATR)
- RR 0.36
- GALT 0.27
- MACD
- RR 0.00
- GALT 0.03
- Stochastic Oscillator
- RR 31.82
- GALT 91.67
About RR Richtech Robotics Inc. Class B
Richtech Robotics Inc is a developer of new robotic technologies focused on transforming labor-intensive services in hospitality and other sectors currently experiencing unprecedented labor shortages. The company designs, manufacture and sells robots to restaurants, hotels, senior living centers, casinos, factories, movie theaters and other businesses. Its robots perform a variety of services including restaurant running and bussing, hotel room service delivery, floor scrubbing and vacuuming, and beverage and food preparation. The company designs its robots to be friendly, customizable to client environments, and extremely reliable.
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.